Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHA:688016)

Market Cap	12.98B -1.8%
Revenue (ttm)	1.35B +12.0%
Net Income	563.21M +12.2%
EPS	4.65 +14.3%
Shares Out	120.91M
PE Ratio	23.09
Forward PE	17.47
Dividend	1.65 (1.52%)
Ex-Dividend Date	Oct 17, 2025

Volume	2,225,433
Average Volume	2,222,498
Open	108.16
Previous Close	108.55
Day's Range	106.01 - 109.68
52-Week Range	81.81 - 124.30
Beta	0.27
RSI	63.93
Earnings Date	Mar 31, 2026

About SHA:688016

Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, and sale of aortic and peripheral vascular medical devices in China and internationally. The company offers branched aortic, thoracic, and bifurcated stent graft system; abdominal aortic stent graft and delivery system; and other stent graft system in surgical operation; as well as accessories, such as balloon inflation catheter. Shanghai MicroPort Endovascular MedTech Co., Ltd. was incorporated in 2012 and is based in Shanghai, the People’...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2012
• Employees: 832
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688016

Financial Performance

In 2025, SHA:688016's revenue was 1.35 billion, an increase of 11.96% compared to the previous year's 1.21 billion. Earnings were 563.21 million, an increase of 12.17%.